BioAdvance News Halo Labs Portfolio News

Halo Labs Launches Aura for Particle and Aggregate ID in Biotherapeutic Development

By WebmasterJune 25, 2020November 1st, 2024No Comments

Halo Labs Launches Aura for Particle and Aggregate ID in Biotherapeutic Development
Aura revolutionizes biologic stability analysis, enabling simple protein and non-protein aggregate identification in formulation development and analytical testing

See more here

Previous PostWellsheet Appoints Dr. Frederik Lindberg, MD, PhD, and Healthcare Executive as VP of Product Management
Next PostMelior Discovery Announces Partnership with SFA on Grant Directed to COVID-19

Halo Labs Launches Aura for Particle and Aggregate ID in Biotherapeutic Development

SEARCH

TOPICS

ARCHIVES

RECENT POSTS

Previous PostWellsheet Appoints Dr. Frederik Lindberg, MD, PhD, and Healthcare Executive as VP of Product Management

Next PostMelior Discovery Announces Partnership with SFA on Grant Directed to COVID-19